Arcadia Biosciences, Inc. — Form D

Arcadia Biosciences, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2009-08-04. The offering totals $15.2M, of which $15.2M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
Steve BrandweinExecutive OfficerPhoenix, AZ
Mark WongDirectorColumbus, OH
Amy YoderRelated PersonDallas, TX
Kevin ComcowichRelated PersonDallas, TX
David CollierDirectorSunnyvale, CA
Kevin T ComcowichDirectorDavis, CA
Albert D BollesDirectorDavis, CA
Lilian Shackelford MurrayDirectorDallas, TX
Lilian Shackelford MurrayRelated PersonDallas, TX
Gregory D WallerDirectorDallas, TX
Gregory D WallerRelated PersonDallas, TX
Amy D YoderDirectorDavis, CA
Matthew T PlavanDirectorDavis, CA
Matthew T PlavanExecutive OfficerDavis, CA
Pam T HaleyExecutive OfficerDavis, CA
Eric ReyExecutive OfficerSeattle, WA
Uday T GargDirectorDavis, CA
Rajendra T KetkarDirectorDavis, CA
Rajendra T KetkarExecutive OfficerDavis, CA
Eric T RayDirectorDavis, CA
Uday J GargDirectorCyber City, Ebene, O4
Darby J ShuppDirectorPhoenix, AZ
Steven J BrandweinDirectorPhoenix, AZ
Eric J ReyDirectorPhoenix, AZ
Eric J ReyExecutive OfficerPhoenix, AZ

Other filings by this issuer (6)

FiledFormOfferingSold
2026-06-26D$11.4M$4.0M
2026-01-27D$6.0M$2.1M
2021-02-16D$25.0M$25.0M
2018-04-11D$10.0M$10.0M
2014-04-25D$35.5M$18.9M
2009-11-25D$12.0M$2.4M

More